Protein release from dihydroxyacetone-based poly(carbonate ester) matrices
Source abstract
Abstract
The release of therapeutics from solid polymer matrices is an important field of study in the area of controlled release. Here we report on the hydrolytic degradation of directly compressed discs comprised of statistically random polycarbonate esters based on lactic acid and dihydroxyacetone. The controlled release of two model proteins, bovine serum albumin and lysozyme, was explored using two percentage loadings (5 and 10 wt.%). A first order release pattern and a trend for faster protein release with increasing dihydroxyacetone content were observed over a time period ranging from 2.5 to 70 days. To analyze the effects of the internal polymer matrix environment on protein stability the enzymatic activity of released lysozyme was monitored. The results show a high level of enzyme activity for the polycarbonate ester ratios with more dihydroxyacetone in the backbone and at least 50% activity over the first month of release from the co-polymer ratios with more lactic acid in the backbone. Modeling of the release kinetics using the Korsmeyer-Peppas model showed a high correlation, indicating that the release of protein is a complex mechanism controlled by protein diffusion through, and erosion of, the co-polymer matrix. The outcomes show that these polycarbonate esters may be useful materials for extended controlled release of proteins.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: biodegradable polymer synthesis and properties · Advanced Drug Delivery Systems · Hydrogels: synthesis, properties, applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. Biodegradable polymers as biomaterials10.1016/j.progpolymsci.2007.05.017 ↗
2. Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)]10.1002/pi.1697 ↗
3. Polymers for biodegradable medical devices. 1. The potential of polyesters as controlled macromolecular release systems10.1016/0168-3659(86)90001-5 ↗
4. Formulation and delivery of proteins and peptides – design and development strategies
5. Polymeric carriers for regional drug-therapy10.1016/S1357-4310(95)80091-3 ↗
6. Chemical syntheses of biodegradable polymers10.1016/S0079-6700(01)00039-9 ↗
7. Controlled drug release from poly(ortho esters)10.1111/j.1749-6632.1985.tb18390.x ↗
8. The controlled parenteral delivery of polypeptides and proteins10.1016/0378-5173(90)90108-G ↗
9. How to achieve sustained and complete protein release from PLGA-based microparticles?10.1016/j.ijpharm.2007.11.012 ↗
10. Morphological characterization of microspheres, films and implants prepared from poly(lactide-co-glycolide) and ABA triblock copolymers: is the erosion controlled by degradation, swelling or diffusion?10.1016/S0939-6411(01)00130-8 ↗
11. Polymeric systems for controlled drug release10.1021/cr940351u ↗
12. Preparation, characterization and biodegradable characteristics of poly(dl-lactide-co-1,3-trimethylene carbonate)10.1002/(SICI)1097-0126(199704)42:4<373::AID-PI722>3.0.CO;2-U ↗
13. In vitro degradation of trimethylene carbonate based copolymers10.1002/mabi.200290000 ↗
14. Synthesis of copolymers of 1,3-dioxan-2-one and oxepan-2-one using coordination catalysts10.1002/pola.1994.080320207 ↗
15. Synthesis, properties, and biodegradation of poly(1,3-trimethylene carbonate)10.1021/ma00008a008 ↗
16. Poly(carbonate-ester)s of dihydroxyacetone and lactic acid as potential biomaterials10.1021/bm101342p ↗
17. Hydrolytic and enzymatic degradation of poly(trimethylene carbonate-co-dl-lactide) random copolymers with shape memory behavior10.1016/j.eurpolymj.2009.12.017 ↗
18. Design of an injectable synthetic and biodegradable surgical biomaterial10.1073/pnas.0811529107 ↗
19. Dihydroxyacetone-containing sunless or self-tanning lotions10.1016/0190-9622(92)70300-5 ↗
20. A mechanistic analysis of the quantitation of α-hydroxy ketones by the bicinchoninic acid assay10.1016/j.ab.2012.08.009 ↗
21. The measurement of lysozyme activity and the ultra-violet inactivation of lysozyme10.1016/0006-3002(52)90045-0 ↗
22. Determination of lysozyme activities in a microplate format10.1016/S0003-2697(02)00320-2 ↗
23. Water diffusion and sorption in amorphous macromolecular systems and foods10.1016/0260-8774(94)90030-2 ↗
24. Quantification of protein concentration by the Bradford method in the presence of pharmaceutical polymers10.1016/j.ab.2010.12.026 ↗
25. Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems10.1016/0168-3659(92)90014-I ↗
26. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems – a review10.1016/j.ijpharm.2011.05.049 ↗
27. Morphological changes in degrading PLGA and P(DL)LA microspheres: implications for the design of controlled release systems10.1080/02652040110065440 ↗
28. Influence of formulation variables on the in vitro release of albumin from biodegradable microparticulate systems10.3109/02652049709051138 ↗
29. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues10.3109/02652049809008253 ↗
30. Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly(d, l-lactic acid-co-glycolic acid) microspheres10.1016/0168-3659(94)00084-8 ↗
31. Biodegradable polymers for use in surgery – poly(glycolic)-poly(lactic acid) homo and co-polymers. 2. In vitro degradation10.1016/0032-3861(81)90168-3 ↗
32. Structure property relationships in the case of the degradation of massive poly(α-hydroxy acids) in aqueous-media. 2. Degradation of lactide–glycolide copolymers – Pla37.5ga25 and Pla75ga25
33. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems10.1016/S0168-3659(01)00248-6 ↗
34. Effect of non-uniform initial-drug concentration distribution on the kinetics of drug release from glassy hydrogel matrices10.1016/0032-3861(84)90082-X ↗
35. A new preparation method for protein loaded poly(d, l-lactic-co-glycolic acid) microspheres and protein release mechanism study10.1016/S0168-3659(98)00050-9 ↗
36. Mechanisms of solute release from porous hydrophilic polymers10.1016/0378-5173(83)90064-9 ↗
37. Solute and penetrant diffusion in swellable polymers. 2. Verification of theoretical-models10.1002/polb.1986.090240215 ↗
38. Analysis of Fickian and non-Fickian drug release from polymers
39. A capacitance study of pseudo-Fickian diffusion in glassy polymer coatings10.1016/0300-9440(95)00601-X ↗
40. Numerical-simulation of anomalous penetrant diffusion in polymers10.1002/app.1993.070491015 ↗
41. Supercritical solvent impregnation of poly(epsilon-caprolactone)/poly(oxyethylene-b-oxypropylene-b-oxyethylene) and poly(epsilon-caprolactone)/poly(ethylene-vinyl acetate) blends controlled release applications10.1016/j.supflu.2008.05.006 ↗
42. Sorption of methylene-chloride in semicrystalline polyethylene terephthalate10.1080/00222349208215516 ↗
43. PLGA based drug delivery systems (DDS) for the sustained release of insulin: insight into the protein/polyester interactions and the insulin release behavior10.1002/jctb.2470 ↗
44. Stochastic-theory of transport in inhomogeneous-media10.1016/0009-2509(86)87104-4 ↗
45. Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres10.1016/S0939-6411(97)00056-8 ↗
46. Immunological studies on egg white proteins. 4. Immunochemical and physical studies of lysozyme10.1016/S0021-9258(18)55926-3 ↗
47. Isoelectric focusing in layers of granulated gels. 1. Thin-layer isoelectric focusing of proteins10.1016/0005-2795(73)90037-8 ↗